ursodeoxycholic acid has been researched along with Cancer, Second Primary in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Florea, A; Harris, RB; Jacobs, ET; Jurutka, PW; Klimentidis, YC; Kohler, LN | 1 |
Hibler, EA; Hu, C; Jacobs, ET; Jurutka, PW; Martinez, ME | 1 |
2 other study(ies) available for ursodeoxycholic acid and Cancer, Second Primary
Article | Year |
---|---|
Circulating Fibroblast Growth Factor-21 and Risk of Metachronous Colorectal Adenoma.
Topics: Adenoma; Aged; Aged, 80 and over; Arizona; Cholagogues and Choleretics; Clinical Trials, Phase III as Topic; Colonic Polyps; Colorectal Neoplasms; Female; Fibroblast Growth Factors; Humans; Male; Middle Aged; Neoplasms, Second Primary; Prospective Studies; Randomized Controlled Trials as Topic; Risk Factors; Ursodeoxycholic Acid | 2021 |
Polymorphic variation in the GC and CASR genes and associations with vitamin D metabolite concentration and metachronous colorectal neoplasia.
Topics: Aged; Clinical Trials, Phase III as Topic; Colorectal Neoplasms; Dietary Fiber; Double-Blind Method; Female; Genetic Predisposition to Disease; Genetic Variation; Genotype; Humans; Male; Middle Aged; Neoplasms, Second Primary; Polymorphism, Single Nucleotide; Randomized Controlled Trials as Topic; Receptors, Calcium-Sensing; Risk Factors; Treatment Outcome; Ursodeoxycholic Acid; Vitamin D; Vitamin D-Binding Protein | 2012 |